128 related articles for article (PubMed ID: 17235472)
1. Does the beta-blocker nebivolol increase coronary flow reserve?
Togni M; Vigorito F; Windecker S; Abrecht L; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
Cardiovasc Drugs Ther; 2007 Apr; 21(2):99-108. PubMed ID: 17235472
[TBL] [Abstract][Full Text] [Related]
2. Unique effect of nebivolol on coronary hemodynamics: it's all a matter of flow.
Lev EI; Battler A
Cardiovasc Drugs Ther; 2007 Apr; 21(2):75-6. PubMed ID: 17417696
[No Abstract] [Full Text] [Related]
3. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease.
Seiler C; Fleisch M; Billinger M; Meier B
J Am Coll Cardiol; 1999 Dec; 34(7):1985-94. PubMed ID: 10588214
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy.
Erdogan D; Gullu H; Caliskan M; Ciftci O; Baycan S; Yildirir A; Muderrisoglu H
Heart; 2007 Mar; 93(3):319-24. PubMed ID: 17065184
[TBL] [Abstract][Full Text] [Related]
6. Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol.
Billinger M; Raeber L; Seiler C; Windecker S; Meier B; Hess OM
Eur Heart J; 2004 Apr; 25(7):565-70. PubMed ID: 15120053
[TBL] [Abstract][Full Text] [Related]
7. Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.
Kurita T; Sakuma H; Onishi K; Ishida M; Kitagawa K; Yamanaka T; Tanigawa T; Kitamura T; Takeda K; Ito M
Eur Heart J; 2009 Feb; 30(4):444-52. PubMed ID: 19098020
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease.
Galderisi M; Cicala S; D'Errico A; de Divitiis O; de Simone G
J Hypertens; 2004 Nov; 22(11):2201-8. PubMed ID: 15480106
[TBL] [Abstract][Full Text] [Related]
9. A new angiographic method to assess coronary flow reserve-validation in humans.
Rittger H; Kuper A; Breithardt OA; Kuon E; Schmidt M; Sinha AM; Blüm B; Jakob A; Brachmann J
Catheter Cardiovasc Interv; 2010 Feb; 75(2):167-73. PubMed ID: 19924776
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
11. The effects of nebivolol on P wave duration and dispersion in patients with coronary slow flow.
Güneş Y; Tuncer M; Güntekin U; Ceylan Y
Anadolu Kardiyol Derg; 2009 Aug; 9(4):290-5. PubMed ID: 19666430
[TBL] [Abstract][Full Text] [Related]
12. Postocclusion hyperemia provides a better estimate of coronary reserve than intracoronary adenosine in patients with coronary artery stenosis.
Nitenberg A; Durand E; Delatour B; Sdiri W; Raha S; Lafont A
J Invasive Cardiol; 2007 Sep; 19(9):390-4. PubMed ID: 17827509
[TBL] [Abstract][Full Text] [Related]
13. Do beta-adrenergic blocking agents increase coronary flow reserve?
Billinger M; Seiler C; Fleisch M; Eberli FR; Meier B; Hess OM
J Am Coll Cardiol; 2001 Dec; 38(7):1866-71. PubMed ID: 11738286
[TBL] [Abstract][Full Text] [Related]
14. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
Lekakis JP; Protogerou A; Papamichael C; Vamvakou G; Ikonomidis I; Fici F; Mavrikakis M
Cardiovasc Drugs Ther; 2005 Aug; 19(4):277-81. PubMed ID: 16187009
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial function in patients with coronary slow flow and the effects of nebivolol.
Gunes Y; Gumrukcuoglu HA; Akdag S; Simsek H; Sahin M; Tuncer M
Arq Bras Cardiol; 2011 Oct; 97(4):275-80. PubMed ID: 22011806
[TBL] [Abstract][Full Text] [Related]
16. Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve. Documentation of a mechanism causing coronary steal in patients with coronary artery disease.
Billinger M; Fleisch M; Eberli FR; Meier B; Seiler C
Cardiovasc Res; 2001 Feb; 49(3):600-8. PubMed ID: 11166273
[TBL] [Abstract][Full Text] [Related]
17. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
[TBL] [Abstract][Full Text] [Related]
19. Functional assessment of the collateral-dependent circulation in chronic total coronary occlusion using transthoracic Doppler ultrasound and venous adenosine infusion.
Pizzuto F; Voci P; Puddu PE; Chiricolo G; Borzi M; Romeo F
Am J Cardiol; 2006 Jul; 98(2):197-203. PubMed ID: 16828592
[TBL] [Abstract][Full Text] [Related]
20. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
